RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Aug. 21, 2006--Gentris Corporation (Gentris), a leading global provider of applied clinical pharmacogenomic services and diagnostic product solutions, today announced the company has partnered with FALCO biosystems Ltd. (FALCO), one of the largest publicly-traded medical testing laboratories in Japan. The exclusive ten-year licensing agreement marks the establishment of Japan’s first Good Laboratory Practice (GLP)-compliant pharmacogenomics laboratory, moving Japan into the era of personalized medicine.
